Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation

Bibliographic Details
Main Authors: Takuma Higurashi, Jun Arimoto, Atsushi Nakajima, Keisuke Ariyoshi, Shunsuke Oyamada, Masataka Taguri, Masato Yoneda, Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Tomoyuki Iwasaki, Takeo Kurihashi, Michihiro Iwaki, Kunihiro Hosono, Eiji Sakai, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Tsutomu Yoshihara, Noboru Misawa, Takayuki Kato, Akiko Fuyuki, Hideyuki Chiba, Machiko Nakatogawa, Ayao Suzuki, Noritoshi Kobayashi, Yasushi Ichikawa
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/5/e060704.full

Similar Items